{
  "N/R/U": null,
  "Applicant": "Kite Pharma Inc.",
  "BLA Number": "125703",
  "Proprietary Name": "Tecartus",
  "Proper Name": "Brexucabtagene Autoleucel",
  "BLA Type": "351(a)",
  "Strength": "2Ã—10^6 CAR-positive viable T cells per kg body weight ",
  "Dosage Form": "For Injection",
  "Route of Administration": "Intravenous",
  "Product Presentation": "Bag",
  "Marketing Status": "Rx",
  "Licensure": "Licensed",
  "Approval Date": "24-Jul-20",
  "Ref. Product Proper Name": " ",
  "Ref. Product Proprietary Name": " ",
  "Supplement Number": "0",
  "Submission Type": "Original",
  "License Number": "2064",
  "Product Number": "1",
  "Center": "CBER",
  "Date of First Licensure": null,
  "Exclusivity Expiration Date": null,
  "First Interchangeable Exclusivity Exp. Date": null,
  "Ref. Product Exclusivity Exp. Date": null,
  "Orphan Exclusivity Exp. Date": "1-Oct-28"
}